AI-driven drug repurposing models using biomedical literature mining

Author(s): Veerendra Nath Jasthi

Publication #: 2508006

Date of Publication: 10.03.2022

Country: United States

Pages: 1-10

Published In: Volume 8 Issue 2 March-2022

DOI: https://doi.org/10.5281/zenodo.16883304

Abstract

Repurposing or discovering new therapeutic application of old drugs is cheaper and more time-saving method of drug discovery. As biomedical literature has been increasing exponentially, artificial intelligence (AI), especially natural language processing (NLP) offers an efficient way of mining this unstructured data to identify repurposing candidates. The given paper investigates the creation and use of drug repurposing models powered by AI and based on biomedical literature mining. The approach combines deep learning, entity recognition and knowledge graph building to find concealed drug-disease connections in a systematic way. The findings show that the model can be used to correctly forecast new drug indications, some of which have a supported view of available evidence (experimental or clinical) of any kind. This paper illuminates the revolutionary nature of AI to facilitate the process of drug repurposing, by automating knowledge gained in large repositories of text.

Keywords: Drug repurposing, artificial intelligence, biomedical literature mining, NLP, deep learning, knowledge graphs, drug discovery, entity recognition.

Download/View Paper's PDF

Download/View Count: 104

Share this Article